Rosa Terribile
Rosa Terribile is in QA at Mipharm and she is a member of the AFI process validation working group.
Articles
Enhancing Process Validation for Sterile Liquid and Freeze-Dried Forms: Part 1
Francesca Speroni;Ilaria Franceschini;Maurizio Valleri;Mauro Silvestri;Matteo De Nigris ;Simona Bertolini;Luca Rizzo ;Alessia Garavaglia ;Camillo Bologna;Rosa Terribile;Stefano Pompilio;Enrico Modena;Stefano Selva;Lorenza Broccardo;Cesare Armetti;Marco Adami
October 16th 2020AFI representatives of the process validation working group explore and define key elements for an enhanced approach to process validation for sterile liquid and freeze-dried forms.
Enhancing Process Validation for Solid Oral Dosage Forms: Part 2
Francesca Speroni;Ilaria Franceschini;Maurizio Valleri;Mauro Silvestri;Matteo De Nigris ;Simona Bertolini;Luca Rizzo ;Alessia Garavaglia ;Camillo Bologna;Rosa Terribile;Stefano Pompilio;Enrico Modena;Stefano Selva;Lorenza Broccardo;Cesare Armetti;Marco Adami
October 16th 2020AFI representatives of the process validation working group explore and define key elements for an enhanced approach to process validation for solid oral dosage forms.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: February 23rd 2024 | Updated: December 21st 2024
Europa Perspectives: Helping to Navigate the Regulatory System
Published: December 13th 2024 | Updated: December 21st 2024
FDA Creates CDER Center for Real-World Evidence Innovation
Published: December 5th 2024 | Updated: December 21st 2024
Leveraging Advancements in Bioanalytical Testing
Published: December 7th 2024 | Updated: December 21st 2024
Exploring Opportunities for LNP Delivery in mRNA
